Parent & Patient Friendly> Switch to Clinical Content
Clinical Perspective & May Not Be Suitable For All Audiences> Switch to Parent & Patient Friendly
Chanarin Dorfman Syndrome: A Patient's Perspective: A Clinical Perspective
What is Chanarin Dorfman Syndrome?
Chanarin-Dorfman syndrome (CDS) or Neutral Lipid Storage Disease with Ichthyosis (NLSDI) is an ultra-rare, recessively inherited form of ichthyosis. Males and females are equally affected. It is caused by mutations in the ABHD5 gene (α/β hydrolase domain-containing protein 5) that codes for a protein also known as CGI-58 [1,2]. This protein is expressed in many tissues of the body and is important in the metabolism of triglyceride lipids. The exact mechanism by which it causes ichthyosis and other abnormalities is not well understood. The clinical description that follows is based on the findings in approximately 50 cases with verified mutations in ABHD5. [REF] Most reported cases have come from the Middle-East or Japan. It is important to note that Neutral Lipid Storage Diseases caused by mutations in genes other than ABHD5 do not have ichthyosis.
What are the Signs and Symptoms?
Individuals who have NLSDI usually present as ichthyosiform erythroderma. Some have been described as collodion babies with ectropion (outward-turned eyelids), eclabion (outward-turned lips). Ichthyosis persists throughout life. Scales are usually small and lightly pigmented on the trunk and extremities. Over body folds the scales may be small, dark and have a corrugated arrangement. Cyclical changes in the amount and character of the scale has caused some individuals to have been mistakenly diagnosed as erythrokeratoderma variabilis. Palms and soles are often minimally involved. Teeth and nails appear normal; hair is normal in texture but sometimes sparse. Insensible water loss in increased in patients with NLSDI and sweating is reduced. Therefore they have increased susceptibility to overheating and heat exhaustion. The skin generally feels dry, while mild and persistent itch is a common complaint.
All tested individuals have had an enlarged liver, and blood enzymes abnormalities suggest involvement of the liver and muscles. Many are reported to have small or misshaped ears, early cataracts, large spleen, mild deafness and mild muscle abnormalities. In contrast to other forms of NLSD which do not have ichthyosis, the muscle and liver disease in NLSDI is generally less severe and progresses slowly, if at all. Less common findings reported in NLSDI include, strabismus (lazy eye), mental retardation and mild growth retardation. The relationship of these less common findings to the mutation in ABHD5 causing the ichthyosis is not well-established. The effect of mutations in ABHD5 on lifespan is unknown (the oldest reported case so far is 62 y.o.). The susceptibility of affected individuals to other common diseases is unknown. Effect on fertility is unknown, although one affected male has had children.
How is it Diagnosed?
Doctors frequently use genetic testing to help define which ichthyosis a person actually has. This may help them to treat and manage the patient. Another reason to have a genetic test is if you or a family member wants to have children. Genetic testing, which would ideally be performed first on the person with ichthyosis or a related skin type, is often helpful in determining a person's, and their relative's, chances to have a baby with ichthyosis. Genetic testing may be recommended if the inheritance pattern is unclear or if you or a family member is interested in reproductive options such as genetic diagnosis before implantation or prenatal diagnosis.
Results of genetic tests, even when they identify a specific mutation, can rarely tell how mild or how severe a condition will be in any particular individual. There may be a general presentation in a family or consistent findings for a particular diagnosis, but it's important to know that every individual is different. The result of a genetic test may be "negative," meaning no mutation was identified. This may help the doctor exclude certain diagnoses, although sometimes it can be unsatisfying to the patient. "Inconclusive" results occur occasionally, and this reflects the limitation in our knowledge and techniques for doing the test. But we can be optimistic about understanding more in the future, as science moves quickly and new discoveries are being made all the time. You can receive genetic testing through the Yale University’s Disorders of Keratinization study with Dr. Keith Choate or for more information about genetic tests performed you can visit GeneDx, www.genedx.com.
What is the Treatment?
Bland emollients give some symptomatic relief. Areas of hyperkeratosis generally respond well to alpha-hydroxy acids or topical retinoids. Improvement of scale without exacerbation of liver abnormalities has been reported with the oral retinoid, acitretin. Reduction in liver size has been reported using a medium-chain triglyceride diet.
1. Lefevre C, Jobard F, Caux F, Bouadjar B, Karaduman A, et al. (2001) Mutations in CGI-58, the gene encoding a new protein of the esterase/lipase/thioesterase subfamily, in Chanarin-Dorfman syndrome. American Journal of Human Genetics 69: 1002-1012.
2. Redaelli C, Coleman RA, Moro L, Dacou-Voutetakis C, Elsayed SM, et al. (2010) Clinical and genetic characterization of Chanarin-Dorfman syndrome patients: first report of large deletions in the ABHD5 gene. Orphanet J Rare Dis 5: 33.
3. Ujihara M, Nakajima K, Yamamoto M, Teraishi M, Uchida Y, et al. (2010) Epidermal triglyceride levels are correlated with severity of ichthyosis in Dorfman-Chanarin syndrome. J Dermatol Sci 57: 102-107.
4. Srinivasaraghavan R, Krishnamurthy S, Chandar R, Cassandrini D, Mahadevan S, et al. (2014) Acitretin-responsive ichthyosis in Chanarin-Dorfman syndrome with a novel mutation in the ABHD5/CGI-58 gene. Pediatr Dermatol 31: 612-614.
Why are the images hidden by default? Can I change this?
All images are copyrighted by FIRST or used with proper consent. They may not be downloaded or re-used for any purpose.
|Other Names:||Neutral Lipid Storage Disease, Disorder of Cornification 12 (Neutral Lipid Storage Type), DOC 12 (Neutral Lipid Storage Type), Ichthyosiform Erythroderma with Leukocyte Vacuolation, Ichthyotic Neutral Lipid Storage Disease, Triglyceride Storage Disease Impaired Long-Chain Fatty Acid Oxidation|
|Age at First Appearance:||birth|
|Longterm Course:||may present with congenital ichthyosiform erythroderma or, rarely, collodian baby; skin changes generally stable after neonatal period; may improve on special diets|
|Diagnostic Tests:||lipid inclusions in cells on blood smear or skin biopsy|
|Abnormal Gene:||PNPLA2 gene, which encodes adipose triglyceride lipase|
- Clinicians seeking to confirm a diagnosis should visit FIRST's TeleIchthyosis site to submit a case to experts in ichthyosis. »
- Learn more about FIRST's Regional Support Network - connecting affected individuals and families with each other. Or call the FIRST office at 800.545.3286. »